These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32923584)

  • 1. Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4
    Rath JA; Bajwa G; Carreres B; Hoyer E; Gruber I; Martínez-Paniagua MA; Yu YR; Nouraee N; Sadeghi F; Wu M; Wang T; Hebeisen M; Rufer N; Varadarajan N; Ho PC; Brenner MK; Gfeller D; Arber C
    Sci Adv; 2020 Jul; 6(27):eaaz7809. PubMed ID: 32923584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells.
    Bajwa G; Lanz I; Cardenas M; Brenner MK; Arber C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33148692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4
    Liang Y; Xu Q; Liu S; Li J; Wang F; Li Z; Liao L; Lu Y; Li Y; Mu F; Sun HX; Zhu L
    Front Immunol; 2022; 13():939940. PubMed ID: 35928827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Generation of TCR and CD8αβ Transgenic Virus Specific T Cells for Immunotherapy of Leukemia.
    Bajwa G; Arber C
    Front Immunol; 2022; 13():830021. PubMed ID: 35572604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
    Ghorashian S; Veliça P; Chua I; McNicol AM; Carpenter B; Holler A; Nicholson E; Ahmadi M; Zech M; Xue SA; Uckert W; Morris E; Chakraverty R; Stauss HJ
    J Immunol; 2015 Feb; 194(3):1080-9. PubMed ID: 25539815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare population of tumor antigen-specific CD4
    Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
    J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
    Minagawa A; Yoshikawa T; Yasukawa M; Hotta A; Kunitomo M; Iriguchi S; Takiguchi M; Kassai Y; Imai E; Yasui Y; Kawai Y; Zhang R; Uemura Y; Miyoshi H; Nakanishi M; Watanabe A; Hayashi A; Kawana K; Fujii T; Nakatsura T; Kaneko S
    Cell Stem Cell; 2018 Dec; 23(6):850-858.e4. PubMed ID: 30449714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC Class I-Restricted TCR-Transgenic CD4
    Schober SJ; Thiede M; Gassmann H; Prexler C; Xue B; Schirmer D; Wohlleber D; Stein S; Grünewald TGP; Busch DH; Richter GHS; Burdach SEG; Thiel U
    Cells; 2020 Jun; 9(7):. PubMed ID: 32610710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular domains of CD8α and CD8ß subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells.
    van Loenen MM; Hagedoorn RS; de Boer R; Falkenburg JH; Heemskerk MH
    PLoS One; 2013; 8(5):e65212. PubMed ID: 23738014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen-specific stem cell memory-like CD4
    Brightman SE; Becker A; Thota RR; Naradikian MS; Chihab L; Zavala KS; Ramamoorthy Premlal AL; Griswold RQ; Dolina JS; Cohen EEW; Miller AM; Peters B; Schoenberger SP
    Nat Immunol; 2023 Aug; 24(8):1345-1357. PubMed ID: 37400675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.
    Au-Yeung BB; Smith GA; Mueller JL; Heyn CS; Jaszczak RG; Weiss A; Zikherman J
    J Immunol; 2017 Mar; 198(6):2445-2456. PubMed ID: 28159902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1
    Shenderov E; Kandasamy M; Gileadi U; Chen J; Shepherd D; Gibbs J; Prota G; Silk JD; Yewdell JW; Cerundolo V
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34088742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase.
    Frankel TL; Burns WR; Peng PD; Yu Z; Chinnasamy D; Wargo JA; Zheng Z; Restifo NP; Rosenberg SA; Morgan RA
    J Immunol; 2010 Jun; 184(11):5988-98. PubMed ID: 20427771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
    Chhabra A; Yang L; Wang P; Comin-Anduix B; Das R; Chakraborty NG; Ray S; Mehrotra S; Yang H; Hardee CL; Hollis R; Dorsky DI; Koya R; Kohn DB; Ribas A; Economou JS; Baltimore D; Mukherji B
    J Immunol; 2008 Jul; 181(2):1063-70. PubMed ID: 18606658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors.
    Vatter S; Schmid M; Gebhard C; Mirbeth C; Klobuch S; Rehli M; Herr W; Thomas S
    J Immunol Methods; 2018 Mar; 454():80-85. PubMed ID: 29154771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
    Bot A; Casares S; Bot S; von Boehmer H; Bona C
    J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.